Progenics Pharmaceuticals, Inc. (PGNX)

Oncology Corporate Profile

Stock Performance

7.0800
0.1200

3 Month Stock History Chart

HQ Location

777 Old Saw Mill River Road
Tarrytown, NY 10591

Company Description

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics' first-in-class PSMA targeted technology platform for prostate cancer includes an antibody drug conjugate therapeutic in a two-cohort phase 2 clinical trial and a small molecule imaging agent that has completed patient dosing in a phase 2 trial. Among other assets in its pipeline of targeted radiotherapy and molecular imaging compounds is Azedra™, an ultra-orphan radiotherapy candidate also in a phase 2 study under an SPA. Progenics' first commercial product, RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for opioid-induced constipation, is partnered with and marketed by Salix Pharmaceuticals, Inc.

Website: http://www.progenics.com

Brand Generic Indication
Relistor®methylnaltrexone bromideRelistor® (methylnaltrexone bromide) is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Use of Relistor® beyond four months has not been studied.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
1404Tc-99m diagnostic imaging agentProstate cancerIII
PyLF-18 diagnostic imaging agentProstate cancerII
1095I-131 small molecule theranosticProstate cancerII
Azedra®I-131 theranostic (MIBG)ParagangliomaII
Azedra®I-131 theranostic (MIBG)Pheochromocytoma¾II
1404PSMA Targeting imaging agentProstate cancerPreclinical

Source: http://www.progenics.com

Recent News Headlines

8/21/2017 06:22 am

8/21/2017 06:22 am

8/21/2017 06:22 am

8/21/2017 06:22 am

8/14/2017 06:19 am

8/14/2017 06:19 am

8/14/2017 06:19 am

8/14/2017 06:19 am

8/14/2017 06:19 am

8/12/2017 12:19 am

8/9/2017 06:19 pm

8/9/2017 06:19 pm

8/9/2017 06:19 pm

8/9/2017 06:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 06:19 am

8/9/2017 12:19 am

8/3/2017 06:20 pm

7/26/2017 12:19 pm

7/26/2017 12:19 pm

7/14/2017 12:19 pm